Genome coding phytolacca antiviral protein and a recombinant exp

Details Genome coding phytolacca antiviral protein and a recombinant exp Genome coding phytolacca antiviral protein and a recombinant exp

1993-10-15

1994-09-20

Wax, Robert A.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

435 713, 435199, 4352523, 43525233, 4353201, 4351723, 536 232, 536 236, 935 11, 935 14, 935 29, 935 56, 935 72, 935 73, C12N 1555, C12N 1529, C12N 1570, C12N 121

Patent

active

053488652

ABSTRACT:
The present inventors discovered a novel genome coding Phytolacca insularis antiviral protein(PIP) isolated from Phytolacca insularis Nakai; and developed a recombinant vector for said PIP genome expression and a microorganism transformed therewith. PIP genome of the present invention has nucleotide hornology of about 82%, compared with the genome of Phytolacca americana antiviral protein isolated from Phytolacca americana L., which is closely related to the Phytolacca insularis Nakai. PIP cDNA is consist of 918 bp of one open reading frame and termination codon; and polyaclenylation signal which is ubiquitous in mRNA of most plants and animals, appears to be located in the upstream of 33 bp from the polyadenylation site. Recombinant PIP of the invention was proved to inhibit the growth of E. coli HB101 transformed with said expression vector.

REFERENCES:
J. D. Irvin-Purification and Partial Characterization of the Antiviral Protein from Phytolacca americana which Inhibits Eukaryotic Protein Synthesis; Arch. Biochem. Biophys., 169, 522-528 (1975).
K. C. Halling et al.-Genomic Cloning and Characterization of a Ricin Gene from Ricinus communis; Nucleic Acid Res., 13, 8019-8033 (1985).
J. Kataoka et al.-DNA Sequence of Mirabilis Antiviral Protein (MAP), a Ribosome-inactivating Protein with an Antiviral Property, from Mirabilis jalapa L. and Its Expression in Escherichia coli; J. Biol. Chem. 266, 8426-8430 (1991).
X. Zhang et al.-Homology of Trichosanthin and Ricin A Chain; Nature, 321, 477-478 (1986).
Y. Endo et al.-The RNA N-Glycosidase Activity of Ricin A-Chain; J. Biol. Chem., 263, 8735-8739 (1988).
J. D. Irvin et al.-Purification and Properties of a Second Antiviral Protein from Phytolacca americana Which inactivates Eukaryotic Ribosomes; Arch. Biochem. Biophys., 200, 418-425 (1980).
B. Jansen et al.-Establishment of a Human t(4;11) Leukemia in Severe Combined Immunodeficient Mice and successful Treatment Using Anti-CD19 (B43)-Pokeweed Antiviral Protein Immunotoxin; Cancer Res., 52, 406-412 (1992).
Y. W. Kim et al.-Immunoconjugates That Neutralize HIV Virions Kill T cells Infected with Diverse Strains of HIV-1; J. Immunol., 144, 1257-1262 (1990).
D. E. Myers et al-Production of a Pokeweed Antiviral Protein(PAP)-containing Immunotoxin, B43-PAP, Directed Against the CD19 Human B Lineage Lymphoid Differentiation Antigen in Highly Purified Form for Human Clinical Trials; J. Immunol. Methods, 136, 221-238 (1991).
M. P. Ready et al.,-Extracellular Location of Pokeweed Antiviral Protein; Proc. Natl. Acad. Sci. USA, 83, 5053-5056 (1986).
Q. Lin et al.-Isolation and characterization of a cDNA Clone Encoding the Anti-viral Protein for Phytolacca americana; Plant Mol. Biol., 17, 609-614 (1991).

Affiliated with

Also associated with

Rating

Genome coding phytolacca antiviral protein and a recombinant exp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genome coding phytolacca antiviral protein and a recombinant exp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genome coding phytolacca antiviral protein and a recombinant exp will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2429795